0NR vs 0RGI: Side-by-Side Comparison
Compare UNIPHAR PLC EO -08 (0NR) and COSMO Pharmaceuticals SA (0RGI) side by side: P/E 23.7 vs 50.2. Financials, growth and model signals on Bullrun.
| Metric | 0NR | 0RGI |
|---|---|---|
| Company | UNIPHAR PLC EO -08 | COSMO Pharmaceuticals SA |
| Country / Exchange | Ireland · F | Ireland · LSE |
| Sector | Healthcare | Healthcare |
| Industry | Medical Distribution | Drug Manufacturers - General |
| Market cap | EUR 1.17B | — |
| P/E ratio | 23.7 | 50.2 |
| Dividend yield | 0.45% | — |
| Valuation model | — | — |
| Revenue (FY2025) | EUR 3.07B | GBP 104.17M |
| Revenue growth YoY | +11.0% | -61.0% |
| Net income | EUR 51.09M | GBP -3.61M |
| Gross margin | 14.9% | 48.5% |
| Diluted EPS | — | — |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.